Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML.

Saved in:
Bibliographic Details
Title: Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML.
Authors: Russell NH; Nigel H. Russell, MD, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Abin Thomas, PhD, Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; and Sylvie D. Freeman, MB ChB, DPhil, School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, United Kingdom., Thomas A; Nigel H. Russell, MD, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Abin Thomas, PhD, Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; and Sylvie D. Freeman, MB ChB, DPhil, School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, United Kingdom., Freeman SD; Nigel H. Russell, MD, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Abin Thomas, PhD, Centre for Trials Research, Cardiff University, Cardiff, United Kingdom; and Sylvie D. Freeman, MB ChB, DPhil, School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, United Kingdom.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 May 20; Vol. 43 (15), pp. 1841-1843. Date of Electronic Publication: 2025 Feb 28.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO-25-00198